Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Wolverine Stack: BPC-157 combined with TB-500 at doses individualized to injury severity
Rather than using the standard 0.25 to 0.5 mg daily dose, micro-dosing protocols employ significantly smaller amounts, typically ranging from 0.1 to 0.15 mg per administration
Refrigeration is recommended to maintain the stability of the peptide, but avoid freezing it
Topical GHK-CU primarily affects the skin directly
Further research by Sikiric et al
In human cosmetic split-face studies (n values typically 20 to 93 participants), measurable skin density and fine-line improvements appear from week 4, with most outcomes reported at 8 to 12 weeks of daily topical use
